Serum Osteopontin as a Novel Biomarker for Muscle Regeneration in Duchenne Muscular Dystrophy
Open Access
- 1 May 2016
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 186 (5) , 1302-1312
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (24591284, 25-5, 22-5)
- National Center of Neurology and Psychiatry (24591284, 25-5, 22-5)
This publication has 42 references indexed in Scilit:
- Osteopontin, inflammation and myogenesis: influencing regeneration, fibrosis and size of skeletal muscleJournal of Cell Communication and Signaling, 2013
- Cleavage of Osteopontin by Matrix Metalloproteinase-12 Modulates Experimental Autoimmune Encephalomyelitis Disease in C57BL/6 MiceThe American Journal of Pathology, 2010
- Osteopontin; as a Target Molecule for the Treatment of Inflammatory DiseasesCurrent Drug Targets, 2010
- Osteopontin: Role in immune regulation and stress responsesCytokine & Growth Factor Reviews, 2008
- Osteopontin expression in coculture of differentiating rat fetal skeletal fibroblasts and myoblastsIn Vitro Cellular & Developmental Biology - Animal, 2006
- Expression Profiling of Cytokines and Related Genes in Regenerating Skeletal Muscle after Cardiotoxin InjectionThe American Journal of Pathology, 2003
- Duchenne Muscular DystrophyJournal of the American Academy of Orthopaedic Surgeons, 2002
- Osteopontin, a Novel Substrate for Matrix Metalloproteinase-3 (Stromelysin-1) and Matrix Metalloproteinase-7 (Matrilysin)Journal of Biological Chemistry, 2001
- Dystrophin–glycoprotein complex: Its role in the molecular pathogenesis of muscular dystrophiesMuscle & Nerve, 1994
- Population frequencies of inherited neuromuscular diseases—A world surveyNeuromuscular Disorders, 1991